The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ANNEXON INC COM 03589W102   17,363,771 3,358,563 SH   SOLE   3,358,563 0 0
ARGENX SE SPONSORED ADR 04016X101   27,853,855 73,526 SH   SOLE   73,526 0 0
ASTRIA THERAPEUTICS INC COM 04635X102   28,311,801 1,901,397 SH   SOLE   1,901,397 0 0
AXSOME THERAPEUTICS INC COM 05464T104   155,158,333 2,011,647 SH   SOLE   2,011,647 0 0
BEIGENE LTD SPONSORED ADR 07725L102   52,663,093 239,443 SH   SOLE   239,443 0 0
BIOCRYST PHARMACEUTICALS INC COM 09058V103   29,194,868 2,543,107 SH   SOLE   2,543,107 0 0
COGENT BIOSCIENCES INC COM 19240Q201   31,893,751 2,758,975 SH   SOLE   2,758,975 0 0
DBV TECHNOLOGIES SA SPONSORED ADR 23306J101   10,809,395 7,064,964 SH   SOLE   7,064,964 0 0
IMARA INC COM 45249V107   2,582,152 631,333 SH   SOLE   631,333 0 0
NEUROCRINE BIOSCIENCES INC COM 64125C109   33,801,520 283,000 SH   SOLE   283,000 0 0
NUVALENT INC COM 670703107   83,055,854 2,788,981 SH   SOLE   2,788,981 0 0
TERNS PHARMACEUTICALS INC COM 880881107   20,767,200 2,040,000 SH   SOLE   2,040,000 0 0
TREVI THERAPEUTICS INC COM 89532M101   10,994,274 5,696,515 SH   SOLE   5,696,515 0 0
TYRA BIOSCIENCES INC COM 90240B106   10,769,185 1,416,998 SH   SOLE   1,416,998 0 0
VERONA PHARMA PLC SPONSORED ADS 925050106   75,137,494 2,875,526 SH   SOLE   2,875,526 0 0
VIRIDIAN THERAPEUTICS INC COM 92790C104   40,006,688 1,369,623 SH   SOLE   1,369,623 0 0